Article info

Download PDFPDF

Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases
Free

Authors

  1. Correspondence to Dr Marcia A Friedman, Medicine, Oregon Health & Science University, Portland, OR 97239, USA; friedmam{at}ohsu.edu
View Full Text

Citation

Friedman MA, Curtis JR, Winthrop KL
Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases

Publication history

  • Received July 27, 2021
  • Accepted August 25, 2021
  • First published September 7, 2021.
Online issue publication 
September 13, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.